SLEEP AND BREATHING / DENTAL / CLINICAL (symposium session): Sam Robinson Memorial Lecture: How do we pick up the pieces when CPAP fails?
Tracks
Track 1
| Friday, November 13, 2026 |
| 1:15 PM - 2:45 PM |
Details
CPAP Failure (intolerance, refusal, inadequacy) affects up to 50% of patients who are prescribed PAP as primary therapy. This symposium aims to explore how we define failure, reasons for failure and salvage options for this cohort of patients. Oral appliance therapy, surgery, nerve stimulation and other salvage treatments are explored in this focused session which will look at the question: How do we pick up the pieces when CPAP Fails?
Speaker
Claire Ellender
How should we define PAP failure and when should we consider alternative treatments?
1:15 PM - 1:35 PMBiography
Prof Olivier Vanderveken
Antwerp University Hospital
Salvaging PAP failure: Personalised treatment
1:35 PM - 1:55 PMBiography
Adam Teo
Director
Qld Dental Sleep Therapy
Can oral appliances help in PAP failure?
1:55 PM - 2:10 PMBiography
Dr Adam Teo is the principal dentist of QLD Dental Sleep Therapy, a clinic dedicated to the management of patients for obstructive sleep apnoea and bruxism with a special focus on oral appliance therapy (mandibular advancement splints). He is a past co-chair of the ASA Dental Sleep Medicine council (2022-2025) and completed his Fellow of Dental Sleep Medicine and Masters in Science of Medicine (Sleep Medicine) in 2023. Adam is a longstanding member of the Australian Dental Association (ADA), Australasian Sleep Association (ASA) is an inductee of the Pierre Fauchard Academy (FPFA) and International College of Dentists (FICD).
Professor Stuart Mackay
Otolaryngologist
Illawarra Ent Head And Neck Clinic
Redefining the timing of "salvage" therapies
2:10 PM - 2:25 PMBiography
Stuart MacKay is an ENT Honorary Clinical Professor (University of Wollongong). Prof MacKay has published around 100 peer reviewed publications related to sleep apnoea surgery, and has been an invited speaker at a multitude of national and international conferences. He was a chief investigator in the NH&MRC funded SAMS trial (JAMA) and the primary publication author. He is also a recipient of a Garnett-Passe Grant for research evaluating upper airway modelling in sleep apnoea. He is currently a co-investigator on a $2 million MRFF grant, and a PI on BEAT-OSA trials and a consultant for CNXII Medical and Somnair.
Prof Garun Hamilton
Director Of Sleep Medicine
Monash Health
Panel discussion: How should we define candidacy for Hypoglossal nerve stimulation therapy in Australia?
2:25 PM - 2:45 PMBiography
Prof Olivier Vanderveken
Antwerp University Hospital
Panel discussion: How should we define candidacy for Hypoglossal nerve stimulation therapy in Australia
2:25 PM - 2:45 PMBiography
Professor Stuart Mackay
Otolaryngologist
Illawarra Ent Head And Neck Clinic
Panel discussion: How should we define candidacy for Hypoglossal nerve stimulation therapy in Australia
2:25 PM - 2:45 PMBiography
Stuart MacKay is an ENT Honorary Clinical Professor (University of Wollongong). Prof MacKay has published around 100 peer reviewed publications related to sleep apnoea surgery, and has been an invited speaker at a multitude of national and international conferences. He was a chief investigator in the NH&MRC funded SAMS trial (JAMA) and the primary publication author. He is also a recipient of a Garnett-Passe Grant for research evaluating upper airway modelling in sleep apnoea. He is currently a co-investigator on a $2 million MRFF grant, and a PI on BEAT-OSA trials and a consultant for CNXII Medical and Somnair.
Claire Ellender
Panel discussion: How should we define candidacy for Hypoglossal nerve stimulation therapy in Australia
2:25 PM - 2:45 PMBiography
Dr Maree Barnes
Sleep Physician
Institute for Breathing and Sleep / Austin Health
Panel discussion: How should we define candidacy for Hypoglossal nerve stimulation therapy in Australia?
2:25 PM - 2:45 PMBiography
Leon Kitipornchai
Chair
Biography
